Eli Lilly CEO expects new weight loss pill to be approved next year
In this article, Eli Lilly CEO David Ricks informed Bloomberg TV on Monday that the company anticipates its experimental weight…
Author: DOC EDITOR
Comcast stock falls after company underwhelms in broadband, Peacock subscribers
Comcast exceeded Wall Street’s fourth-quarter estimates despite facing larger-than-expected losses in broadband subscribers and stagnant paid subscribers for its streaming…
FDA approves J&J’s nasal spray for depression as stand-alone treatment
In this article, the Food and Drug Administration has approved Johnson & Johnson’s nasal spray, Spravato, for use alone in…
FTC sues PepsiCo, alleging price discrimination is raising costs for consumers
In this article, the Federal Trade Commission announced on Friday that it is taking legal action against PepsiCo for alleged…
Comcast shifts strategy to mobile as fourth-quarter broadband numbers disappoint
In this article, cable giant Comcast is shifting its focus to the wireless business for growth. The company reported a…
Oracle announces new AI-powered electronic health record
In this article, Oracle introduced a new electronic health record on Tuesday, marking its most significant health-care product update since…
NHL plans to host two outdoor games in Florida in 2026
Outdoor hockey in Florida? The National Hockey League is ready for the challenge. The NHL recently announced plans to hold…
Key Fed measure shows core inflation at 2.8%, in line with expectations
Inflation closed out 2024 on a strong note, according to the Commerce Department’s report on Friday. The personal consumption expenditures…
FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage
In this article, the Food and Drug Administration announced that the shortage of tirzepatide injection products, the active ingredient in…